# clm_8C716505DCB2

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_net_income  
value: 3,052,000,000 United States dollar  
valid_from: 2025-09-30  
valid_to: 2026-03-31  
published: 2025-11-07  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_24FF1FC3A935  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly net income: 3,052,000,000 United States dollar", as of 2025-09-30 (until 2026-03-31). Claim clm_8C716505DCB2, https://asof.is/claim/clm_8C716505DCB2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209525000047/0000882095-25-000047-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-11-07  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209525000047/0000882095-25-000047-index.htm (primary, SEC EDGAR 10-Q Q3 FY2025, published 2025-11-07)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_net_income | 1,960,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_8C716505DCB2](/claim/clm_8C716505DCB2.md) | [clm_96F4B471EBB0](/claim/clm_96F4B471EBB0.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.